Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer Enhanc3D Genomics appoints Dr Daniel Turner as Chief Scientific Officer Appointment forms part of ongoing plans for continued development of the GenLink3D genomics platform and formation of strategic commercial and academic partnerships CN Bio appoints Joseph Parisi as US Director of Sales CN Bio appoints Joseph Parisi as US Director of Sales CN Bio, a leading Organ-on-a-Chip (OOC) company that designs and manufactures single- and multi-organ microphysiological systems (MPS), announces the appointment of Joseph... EpiEndo Pharmaceuticals extends its scientific advisory board EpiEndo Pharmaceuticals extends its scientific advisory board The expansion broadens the board’s expertise, bringing a fresh perspective and years of industry experience BCMPA announces the death of Rodney Steel BCMPA announces the death of Rodney Steel It is with great regret that the BCMPA announces that Rodney Steel, former CEO of the BCMPA, has died following a short illness Rob Orford OBE named new Chief Executive of Moondance Cancer Initiative Rob Orford OBE named new Chief Executive of Moondance Cancer Initiative Wales’ most senior healthcare scientist has taken on a new role to further improve cancer outcomes Jean-Marc Huët to succeed Albert M. Baehny as Chair of Lonza Jean-Marc Huët to succeed Albert M. Baehny as Chair of Lonza The board look forward to welcoming Jean-Marc Huët into the position of Chairperson BICO Group AB announces Catharina Nordlund as their new Global Head of HR BICO Group AB announces Catharina Nordlund as their new Global Head of HR Ms Nordlund will further strengthen the Executive Management and be responsible for shaping and executing BICO’s global HR strategy Cellular Origins appoints Peter Crossley as Chief Operating Officer Cellular Origins appoints Peter Crossley as Chief Operating Officer Cellular origins, a TTP company, recently appointed Peter Crossley as the COO after 27 years of industry experience Onyx Scientific targets stateside expansion with new appointment Onyx Scientific targets stateside expansion with new appointment Leading small molecule CDMO Onyx Scientific is set to expand its commercial operations in the United States with the appointment of Anthony Harbour as Business Development... AES Clean Technology expands senior leadership team with key appointment AES Clean Technology expands senior leadership team with key appointment A leading provider of high-performance cleanroom facilities, AES Clean Technology, has appointed Brian Weed as Chief Revenue Officer (CRO) SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit SGD Pharma announces the appointment of Fabio Invernizzi, General Manager West Business Unit The BU West includes SGD Pharma’s commercial activities for MEA, North and South America and our manufacturing footprint in Europe Nuclera announces the appointment of Jonathan Milner as Chairman of the Board Nuclera announces the appointment of Jonathan Milner as Chairman of the Board Nuclera, the pioneer in bringing rapid protein prototyping to the benchtop, is delighted to announce the appointment of Jonathan Milner as the Non-executive Chairman of the... Corteria Pharmaceuticals appoints Mark Pruzanski as Chair of its Board of Directors Corteria Pharmaceuticals appoints Mark Pruzanski as Chair of its Board of Directors Corteria Pharmaceuticals, a biopharmaceutical company specialised in the development of transformative therapies for heart failure and obesity, announces the appointment of... X‑Chem transitions executives into new roles, appoints new Chief Executive Officer X‑Chem transitions executives into new roles, appoints new Chief Executive Officer X-Chem, the leading provider of innovative solutions in early-stage drug discovery, today announced executive management team changes aimed at expanding its position as a... 2cureX announces changes to the Board of Directors 2cureX announces changes to the Board of Directors 2cureX, a pioneer in the use of 3D tumoroids for predicting cancer treatment efficacy, is implementing significant changes in its governance resulting in four Board members... Stuart Quin joins GHO Capital as Partner Stuart Quin joins GHO Capital as Partner Former CEO of Medica Group and regional CEO of Synlab to support the continued growth of GHO Capital’s portfolio and origination of future investments